Rewalk Robotics LTD
Seite 1 von 10 Neuester Beitrag: 03.04.24 13:46 | ||||
Eröffnet am: | 12.02.15 13:19 | von: iwanooze | Anzahl Beiträge: | 236 |
Neuester Beitrag: | 03.04.24 13:46 | von: Buddelflink | Leser gesamt: | 74.504 |
Forum: | Hot-Stocks | Leser heute: | 38 | |
Bewertet mit: | ||||
Seite: < 1 | 2 | 3 | 4 | 7 | 8 | 9 | 10 10 > |
ReWalk Robotics Stock Up 56%: Great Origin Story, Poor Financial Prospects
https://www.forbes.com/sites/petercohan/2021/09/...s/?sh=2cf23dbc13d9
Hier nur kurz der Einstieg:
Since going public about seven years ago, shares in ReWalk Robotics, a Marlborough, Massachusetts-based robotic exoskeleton provider, had plummeted about 99.7% as of September 24.
But this week, 49-employee ReWalk was the fourth most active stock in the U.S., according to Trading View, as it soared 56% to a market capitalization of $100 million.
With active bullish discussion about the shares on Stocktwits, is it too late to jump on the ReWalk bandwagon? I see three reasons to avoid this stock:
Out-of-reach expectations and scrambles to avoid delisting
Weak financial outlook
Plunging short-interest
Oder dass die FDA heute tolle Neuigkeiten berichten wird?
FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit
NOV 4, 2021 4:30PM EDT
Soft exoskeleton device for stroke survivors will be for use at home and in the community to help with walking and mobility
MARLBOROUGH, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA). The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological injuries, such as stroke. The ReBoot is a customizable personalized device intended for home and community use. It is a sister product to the ReStore device, which received FDA clearance in 2019 for use in the rehabilitation setting.
Breakthrough device designation from the FDA is a critical milestone for the ReBoot, as it provides a more streamlined review pathway that can get this uniquely innovative device to market faster, said Larry Jasinski, CEO of ReWalk. The ReBoot will give stroke survivors a device customizable for each individual user, giving them the opportunity for regular assistance at home and in the community.
Hier die ganze Meldung
https://www.nasdaq.com/press-release/...-reboot-soft-exo-suit-2021-11
Vielleicht komm ich hier ja doch noch zurück ins Plus...
https://seekingalpha.com/article/...robotics-catalysts-on-the-horizon
So wie ich das sehe schuldenfrei ... MK 38 Mio bei Cash 65 Mio .
dazu die IP Patente die mE um einiges mehr wert sein sollten als die aktuelle MK ...
Ich frage mich ...Übernahmkandidat ..... für ein größeres Unternehmen welches an die Patente ran will .. ..immerhin bekommst das Unternehmen umsonst + Cash oben drauf ..
Wird hier in Player zuschlagen ....
Parker ..
EksoBionics ..
?
Hätte mal wissen wollen was passiert wäre, wenn ich das Geld bereits anderweitig wieder investiert hätte. Hätte ich dann Schulden im Depot gehabt? Weil das Geld wurde mir ja direkt nach der "erfolgreichen" Ausführung gutgeschrieben...